DelistingJun 1, 2026, 05:00 PM
iSpecimen Receives Nasdaq Delisting Notice for Equity Non-Compliance
AI Summary
iSpecimen Inc. received a notice from Nasdaq on May 29, 2026, indicating non-compliance with the minimum stockholders' equity requirement of $2,500,000 for continued listing on the Nasdaq Capital Market. The company's reported stockholders' equity was $814,038 as of March 31, 2026, and it also fails to meet alternative listing standards. The notice does not immediately affect the trading of its common stock, and iSpecimen plans to submit a compliance plan within 45 days.
Key Highlights
- iSpecimen received a notice from Nasdaq for non-compliance with Listing Rule 5550(b)(1).
- The rule requires a minimum of $2,500,000 in stockholders' equity for continued listing.
- iSpecimen reported stockholders' equity of $814,038 as of March 31, 2026.
- The company also does not meet alternative listing standards for market value or net income.
- iSpecimen has 45 calendar days from May 29, 2026, to submit a plan to regain compliance.
- If accepted, Nasdaq may grant an extension of up to 180 calendar days from the notice date.
Price Impact
More from ISPC